GPT and fatty liver disease: Resulted in a decrease in serum levels of total triglyceride (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), alanine transaminase (ALT), and free fatty acids (FFA), as well as a reduction in fasting blood glucose (FBG) and inhibition of hepatic steatosis.